Clinical studies on the arbaclofen and ganaxolone indicate that GABA agonists have potential for treating FXS, and thus AEDs increasing GABA-ergic transmission, such as VGB, TGB, GBP, TPM, may also be beneficial [16,17,18]. This evidence concerns the gene PPBP and fragile X syndrome.